Coronary disease & ACS

Chest pain patterns and coronary microvascular function in non-obstructive coronary artery disease

EuroInterventionPublished Serial patients with and non-obstructive coronary arteries (ANOCA) who underwent coronary reactivity testing

Authors' conclusion

ANOCA patients with exertional CP demonstrated worse microvascular function than those with resting CP, with endothelium-independent CMD showing a significant prognostic impact. Exertional CP patients may benefit more from treatment strategies specifically targeting CMD.

Study context

Population
Patients with angina and non-obstructive coronary arteries (ANOCA) who underwent coronary reactivity testing
Participants
1,264 patients
Comparison
Microvascular function and prognosis were compared between patients with exertional CP and resting CP.
Outcome
CP pattern distribution

Main finding

As reported in the abstract

Median age
52 years
Women
65.3%

Further findings

OutcomeExertional CPResting CPBothP value
CFRExertional CP vs Resting CP · lower in exertional CP2.83.0Not reported in the abstractP = 0.014Both: not reported in the abstract
Endothelium-independent CMD prevalenceExertional CP vs Resting CP · higher in exertional CP32.1%24.4%Not reported in the abstractP = 0.034Both: not reported in the abstract
CBF increase in response to acetylcholineExertional CP vs Resting CP · lower in exertional CP38.2%50.7%Not reported in the abstractP = 0.015Both: not reported in the abstract

Prognostic impact of endothelium-independent coronary microvascular dysfunction (CMD) (survival analysis) · median 7-year follow-up

Endothelium-independent CMD significantly increased risk in exertional CP patients
P = 0.002
Not in resting CP patients
P = 0.388

Original publication

Chest pain patterns and coronary microvascular function in non-obstructive coronary artery disease. EuroIntervention. Published 1 September 2025. doi:10.4244/eij-d-25-00277

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.